Barrington Research Upgrades OPKO Health to Outperform, Announces $2 Price Target
Portfolio Pulse from richadhand@benzinga.com
Barrington Research analyst Michael Petusky has upgraded OPKO Health (NASDAQ:OPK) from Market Perform to Outperform and set a price target of $2.
June 29, 2023 | 1:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OPKO Health has been upgraded to Outperform by Barrington Research with a price target of $2.
The upgrade from Market Perform to Outperform by Barrington Research indicates a positive outlook for OPKO Health. The set price target of $2 also suggests potential upside for the stock. This could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100